Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1) Peptide
-
- Target See all AGGF1 products
- AGGF1 (Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- EYEDEKTLKN PKYKDRAGKR REQVGSEGTF QRDDAPASVH SEITDSNKGR
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of AGGF1 antibody,
Alternative Names: AGGF1 control peptide, AGGF1 antibody Blocking Peptide, Anti-AGGF1 Blocking Peptide, Angiogenic Factor With G Patch And Fha Domains 1 Blocking Peptide, FLJ10283 Blocking Peptide, GPATC7 Blocking Peptide, GPATCH7 Blocking Peptide, HSU84971 Blocking Peptide, HUS84971 Blocking Peptide, VG5Q Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- AGGF1 (Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1))
- Background
- The AGGF1 gene encodes a potent angiogenic factor that contains a forkhead-associated domain and a G-patch domain.
- Molecular Weight
- 81 kDa
-